Cargando…
A Quantitative Proteomic Approach to Identify Significantly Altered Protein Networks in the Serum of Patients with Lymphangioleiomyomatosis (LAM)
Lymphangioleiomyomatosis (LAM) is a rare and progressive cystic lung condition affecting approximately 3.4–7.5/million women, with an average lag time between symptom onset and diagnosis of upwards of 4 years. The aim of this work was to identify altered proteins in LAM serum which may be potential...
Autores principales: | Banville, Nessa, Burgess, Janette K., Jaffar, Jade, Tjin, Gavin, Richeldi, Luca, Cerri, Stefania, Persiani, Elisa, Black, Judith L., Oliver, Brian G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4136818/ https://www.ncbi.nlm.nih.gov/pubmed/25133674 http://dx.doi.org/10.1371/journal.pone.0105365 |
Ejemplares similares
-
Lymphangioleiomyomatosis (LAM)
Publicado: (2017) -
Pregnancy after the diagnosis of lymphangioleiomyomatosis (LAM)
por: Shen, Lisha, et al.
Publicado: (2021) -
“Getting stuck with LAM”: patients perspectives on living with Lymphangioleiomyomatosis
por: Belkin, Amanda, et al.
Publicado: (2014) -
LAM Cells as Potential Drivers of Senescence in Lymphangioleiomyomatosis Microenvironment
por: Bernardelli, Clara, et al.
Publicado: (2022) -
Pulmonary lymphangioleiomyomatosis (LAM): A literature overview and case report
por: Cong, Cung-Van, et al.
Publicado: (2022)